OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit www.conferenceseries.com

Back

Liang Xu

Liang Xu

University of Kansas
USA

Biography

Liang Xu is a professor in the Department of Molecular Bioscience in University od Kansas. The goal of the proposed research is to establish nanovectors as a gene/miRNA delivery platform to develop novel molecular therapies targeting cancer stem cells. In summary he has a demonstrated record of successful and productive research projects relevant to the his research field and his expertise and experience have prepared him to go for invention of a new direction in cancer research.

Research

Molecular therapy targeting cancer and cancer stem cells, cancer biology, drug discovery and drug/gene delivery.(Funded by multiple NIH and DOD grants). Molecularly targeted cancer therapy and chemo/radiosensitization by modulating cell death signaling pathways, autophagy and apoptosis. Exploring microRNAs as novel targets for cancer and cancer stem cells. Nanovectors targeting cancer cells for siRNA/miRNA-based novel cancer therapeutics. Nanovectors targeting cancer stem cells and exploring novel molecular therapy for cancer stem cells.